Lataa...
PARATHYROID HORMONE RECEPTOR MEDIATES THE ANTI-MYELOMA EFFECT OF PROTEASOME INHIBITORS
Clinically significant serum parathyroid hormone (PTH) variations have been reported in multiple myeloma (MM) patients treated with proteasome inhibitors. To elucidate the association between serum PTH variations and proteasome inhibition in MM, the effect of PTH and PTHR1 ligands on the proteasome...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3967551/ https://ncbi.nlm.nih.gov/pubmed/24389365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2013.12.025 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|